Skip to main content
. 2024 Oct 7;29(19):4737. doi: 10.3390/molecules29194737

Figure 5.

Figure 5

Anti-cancer therapeutic strategies using aptamer-based protein inhibition. (A) Schematic image of multimeric aptamer for EpCAM and PDGF protein inhibition. (B) Schematic image of bispecific aptamer for lysosomal degradation of target membrane proteins with IGFIIR-mediated lysosomal proteolysis systems. (C) Schematic image of bispecific aptamer for target membrane receptor inhibition by thrombin-mediated cleavage. (Adapted from Refs. [134,138,139]).